Chuck Schumer says the Senate will very soon vote on a bipartisan bill to lower insulin prices


Senate Majority Leader Sen. Chuck Schumer (D-NY) said the Senate will vote very soon on a bipartisan bill to lower the cost of insulin.

Majority Leader Schumer said in a statement provided to PoliticusUSA:

The cost of insulin has skyrocketed in recent years, and the INSULIN Act will make this lifesaving drug more affordable by capping the cost of insulin at $35 per month, changing the high price system that drives profits before patients and helping to reduce costs for millions of Americans with diabetes. I will be tabling this bipartisan legislation on the floor of the Senate very soon – it should pass quickly. I praise the senses. Shaheen and Collins for their collaboration. This bill represents months of thoughtful consideration by both parties.

There should be nothing remotely partisan about making sure Americans don’t go broke trying to manage their diabetes. At least one in four insulin users say they ration their use because they cannot afford it, putting their health and life at risk. The bipartisan legislation of Senators Shaheen and Collins deserves the support of anyone who claims to want to cut costs for the American people.

The bipartisan INSULIN law ties the maximum price that can be charged for insulin to the price negotiated by Medicare Part D. Currently, the maximum price is $35/month. Bill of Sens. Shaheen (D) and Collins (R) are expected to pass the Senate and House.

Earlier, 193 Republicans voted against the House bill to lower the price of insulin to $35.

Along with the recently announced gun control bill, the INSULIN Act will be another bipartisan achievement of President Biden.

Reducing the maximum insulin cost will also reduce the insurance co-payment for insulin to zero.

Tens of millions of Americans depend on insulin for their survival, and their price should not be abused for any medical condition.


Please enter your comment!
Please enter your name here